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Abstract 
DNA accessibility is thought to be of major importance in regulating gene expression. We test 
this hypothesis using a restriction enzyme as a probe of chromatin structure and as a proxy for 
transcription factors. We measured the digestion rate and the fraction of accessible DNA at 
almost all genomic AluI sites in budding yeast and mouse liver nuclei. Hepatocyte DNA is more 
accessible than yeast DNA, consistent with longer linkers between nucleosomes, and suggesting 
that nucleosome spacing is a major determinant of accessibility. DNA accessibility varies from 
cell to cell, such that essentially no sites are accessible or inaccessible in every cell. AluI sites in 
inactive mouse promoters are accessible in some cells, implying that transcription factors could 
bind without activating the gene. Euchromatin and heterochromatin have very similar 
accessibilities, suggesting that transcription factors can penetrate heterochromatin. Thus, DNA 
accessibility is not likely to be the primary determinant of gene regulation. 
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Genomic DNA is packaged into chromatin, which is composed of regularly spaced nucleosomes. 
Human and mouse cells contain relatively open euchromatin (similar to yeast chromatin) and 
extremely compact heterochromatin (Becker et al. 2016; Allshire and Madhani 2018). Most 
genes located in heterochromatin are completely repressed (Becker et al. 2016). Controlling the 
accessibility of DNA to transcription factors is thought to be of major importance in regulating 
gene activation, primarily through precise positioning of a nucleosome over regulatory elements 
such as promoters and enhancers, blocking access to transcription factors (Fig. 1A). Activation is 
thought to occur when an ATP-dependent chromatin remodeler removes the blocking 
nucleosome, allowing transcription factors to bind, although precisely how remodelers are 
targeted to regulatory elements is still unclear (Voss and Hager 2014; Venkatesh and Workman 
2015). DNA accessibility may also be modulated at higher levels of chromatin structure (Fig. 
1A): linker histone-dependent condensation of the chromatin filament may limit access to linker 
DNA between nucleosomes. Furthermore, large-scale compaction may occlude transcription 
factors from heterochromatin domains, perhaps involving liquid droplet phase separation (Larson 
et al. 2017). If DNA accessibility is the primary determinant of gene regulation, then it is crucial 
for repression that critical regulatory elements are blocked in all cells in a population. Otherwise, 
there would be inappropriate gene activation in some cells. 
The accessibility model described above is appealing, but it has not yet been tested using 
a fully quantitative genome-wide assay. MNase-seq data are difficult to quantify because 
micrococcal nuclease destroys the DNA as digestion proceeds. Furthermore, nucleosomes are 
digested at different rates depending on the sequences they contain, resulting in apparently 
different relative occupancies as digestion proceeds (Chereji et al. 2017; Schwartz et al. 2018). 
MNase-seq data are typically normalized to the genomic average and relative nucleosome 
occupancies are estimated, although they are still subject to the caveat above. Three other 
valuable methods, DNase-seq (John et al. 2011), ATAC-seq (which uses a transposase) (Schep et 
al. 2015) and RED-seq/NA-Seq (which use restriction enzymes) (Gargiulo et al. 2009; Chen et 
al. 2014) report the relative accessibilities of open regions in chromatin. Small DNA fragments 
excised from accessible DNA sequences (typically regulatory elements) are isolated and 
sequenced. However, the rest of the genome is excluded from the analysis because it is still 
present as very long DNA molecules. Consequently, the signal and relative amounts of each 
accessible element depend on the extent of digestion or, in the case of ATAC-seq, on the extent 
 Cold Spring Harbor Laboratory Press on May 14, 2020 - Published by genome.cshlp.orgDownloaded from 
4 
of transposition, allowing only relative measurements. Since these methods sequence only the 
small fraction of accessible DNA fragments, they are only semi-quantitative. 
We have adapted the restriction enzyme protection assay to measure accessibility 
(Linxweiler and Hörz 1984; Fascher et al. 1990; Jack and Eggert 1990; Archer et al. 1991; 
Verdin et al. 1993; Wallrath and Elgin 1995; Shen et al. 2001). This assay measures both the 
absolute accessibility of the DNA and the rate at which accessible sites are cut. It has been used 
in vitro to monitor nucleosome reconstitution (Zheng and Hayes 2003), to detect nucleosome 
shifts (Studitsky et al. 1994) and to measure the activities of chromatin remodeling enzymes 
(Tsukiyama and Wu 1995). It depends on the fact that restriction enzymes are essentially unable 
to cut their cognate sites within a nucleosome (Linxweiler and Hörz 1984; Polach and Widom 
1995). Restriction enzymes cut nucleosomal DNA 102 - 105 times slower than linker DNA, with 
faster rates for DNA just inside the nucleosome, as it is more likely to dissociate transiently from 
the histone octamer (Polach and Widom 1995; Chereji and Morozov 2014). These large rate 
differences result in a plateau in the digestion, corresponding to the fraction of accessible DNA 
(Fig. 1B; Supplemental Material). Here, we use the restriction enzyme protection assay to 
measure the accessibility of a large number of specific sites throughout the genome in nuclei 
from budding yeast and mouse liver.  
 
Results 
A fully quantitative measure of DNA accessibility: qDA-seq. We used the restriction enzyme 
AluI to measure both the absolute DNA accessibility (i.e. the fraction of the DNA that is 
accessible to AluI) and the initial rate at which these accessible sites are cut. This simple method, 
which we term “quantitative DNA accessibility” assay (qDA-seq), involves treating nuclei with a 
restriction enzyme at different concentrations, sonicating the DNA into small fragments, 
followed by paired-end sequencing (Supplemental Fig. S1). The sonication step is necessary 
because the AluI digest contains many long DNA fragments derived from protected chromatin, 
which are not suitable for Illumina sequencing. 
AluI cuts the sequence AG|CT to yield blunt ends. The yeast genome has ~40,000 AluI 
sites; the mouse genome has ~12.6 million sites. After sequencing, we calculate the fraction of 
DNA molecules cut at each AluI site as a function of AluI concentration up to ~50 nM. The 
accessible fraction is measured by counting the number of DNA molecules with an end 
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corresponding to a specific genomic AluI site as a fraction of all DNA molecules containing the 
same site. A direct comparison of accessible fractions in different cell types is possible; 
critically, no normalization is necessary. We note that although most of the protection observed 
is likely to be due to nucleosomes, the nucleosome may not be the only complex that is resistant 
to restriction enzymes. Such complexes would have to be stable enough to protect an AluI site 
during the 20 minute incubation. 
 
DNA accessibility in yeast varies from cell to cell. To avoid potential complications due to 
increased accessibility of replicating DNA, we arrested haploid yeast cells in the G1 phase of the 
cell cycle using α-factor. Nuclei were digested with increasing concentrations of AluI and the 
expected plateau was observed at essentially all AluI sites (see below). It is important to note that 
only one copy of a unique genomic sequence is present in each cell, because the cells are 
haploid. Therefore, the plateau value indicates the fraction of cells in which a particular unique 
AluI site is accessible. Each site is accessible in some cells and inaccessible in the other cells. 
We present the ARG1 gene as an example (Fig. 2A). Digestion at an AluI site (site 2; Fig. 
2A) just inside the -1 nucleosome reaches a plateau at ~45% cut, indicating that this site is 
accessible in ~45% of the cells and inaccessible in the remaining ~55% of cells. A neighbouring 
AluI site (site 3) located close to the upstream border of the nucleosome-depleted region (NDR) 
at the ARG1 promoter is more accessible, at ~50%. In contrast, all three AluI sites in the ARG1 
coding region (sites 4, 5 and 6; located within the +2, +3 and +7 nucleosomes respectively) have 
lower accessibilities (~15-20%), suggesting that nucleosome occupancy is higher on the coding 
region (~75-80%), consistent with MNase-seq data (Fig. 2A), and indicating that these sites are 
accessible in only 1 in 4 or 5 cells. The AluI site in the YOL057W promoter downstream of 
ARG1 (site 8) is much more accessible, but the digestion still reaches a plateau at ~60%, 
indicating that this site is protected in ~40% of cells, even though the MNase-seq data show that 
it is located within a deep NDR, predicting a nucleosome occupancy close to 0 (Fig. 2A). 
Instead, we attribute this protection to non-histone proteins stably bound at the YOL057W 
promoter in ~40% of cells (Chereji et al. 2017). Importantly, a plateau is reached at all AluI sites, 
indicating that each site is accessible in some cells and protected in the remaining cells. We 
obtained similar data for ARG1 sites 5 and 8 using duplex qPCR (Supplemental Fig. S2). 
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For genome-wide analysis of the data, we superimposed the plots for all ~40,000 AluI 
sites (Fig. 2B). A plateau is reached at a median accessibility of ~22%, indicating that the 
median AluI site is inaccessible in ~78% of cells. The data range shows that 90% of AluI sites 
are cut in only ~9% - 55% of cells (Fig. 2B). This observation indicates that yeast cells are very 
heterogeneous in DNA accessibility. In particular, we note that none of the ~40,000 AluI sites is 
accessible in >95% of cells. Moreover, of 96 AluI sites that are apparently inaccessible in both 
replicate experiments (0% cut), at least 78% are sites present in the S288C genome sequence but 
not in our strain (which is derived from W303), i.e., these AluI sites are absent in our strain due 
to polymorphisms and deletions. To gain more insight, we divided the AluI sites into gene body 
sites and promoter sites (Fig. 2C). The median accessibility in gene bodies is very similar to that 
for all sites (~20%), because gene bodies account for a very large fraction of the yeast genome. If 
we make the simple assumption that a nucleosome protects 147 bp of every 165 bp (the average 
nucleosome spacing in yeast (Thomas and Furber 1976)), the predicted protection is 89% 
(147/165), which is higher than observed (~80%), suggesting that there may be some digestion 
just inside the nucleosome as observed in vitro (Polach and Widom 1995), or that there may be 
occasional gaps in the nucleosomal arrays. In the former case, a value of 80% is consistent with a 
protected inner nucleosome core of 132 bp (80% of 165 bp), suggesting that the outer ~7 bp on 
both sides of the nucleosome are vulnerable to AluI. 
The median accessibility of promoters, defined by their NDRs, is ~53% (range: 90% of 
sites cut in 22% - 78% of cells), which is much higher than in gene bodies, and consistent with 
nucleosome depletion. However, digestion within the NDR still reaches a plateau, indicating the 
presence of stable complexes protecting the NDR in about half of the cells, presumably 
corresponding to non-histone barrier complexes (Chereji et al. 2017). Estimation of AluI 
digestion rates at accessible sites in promoter NDRs and genes, assuming first order kinetics (see 
Supplemental Material), indicates that NDR sites are digested only ~1.3 times faster than linker 
DNA sites in gene bodies (Fig. 2B, C; Supplemental Fig. S3). 
 
Imperfect nucleosome positioning can account for cell-to-cell heterogeneity in DNA 
accessibility. We plotted the mean AluI accessibility for all ~5,000 yeast genes as a function of 
distance from the first (+1) nucleosome on the gene, which typically covers the transcription start 
site (TSS) in yeast (Mavrich et al. 2008) (Fig. 3A). The extent of digestion as a function of AluI 
 Cold Spring Harbor Laboratory Press on May 14, 2020 - Published by genome.cshlp.orgDownloaded from 
7 
concentration is shown. In the absence of AluI, there is a background of ~1% cut, corresponding 
to random fragmentation of the DNA at an AluI site by sonication. Digestion increases with 
increasing AluI concentration up to ~15 nM, beyond which there is no more digestion. There is a 
strong peak at the NDR, with a maximum mean value of ~55% cut. Promoters are more 
accessible than gene bodies, but a resistant complex is present in about half of the cells. 
In gene bodies, an oscillatory pattern is observed around a mean value of ~25% 
accessibility, anti-correlated with phased nucleosomes observed in MNase-seq data, such that the 
AluI peaks coincide with linkers and the AluI troughs coincide with nucleosomes. The amplitude 
of this oscillation provides a quantitative estimate of the degree of phasing. Perfectly phased 
nucleosomal arrays (i.e., each nucleosome occupies an identical position in every cell) predict 
100% cutting at AluI sites in linkers (i.e., cut in all cells) and 0% cutting at nucleosomal sites 
(i.e., blocked in all cells). In fact, the oscillations are relatively weak: the average probability of 
cutting an AluI site located at the +1 nucleosome position is ~15%, compared to ~35% for AluI 
sites in linkers. Thus, the +1 nucleosome is shifted or absent in ~15% of cells. These data can be 
explained by a model in which regularly spaced nucleosomes are positioned slightly differently 
in different cells, such that an AluI site is protected in ~80% of cells and in an accessible linker 
in ~20% of cells (Fig. 3B). Similarly, promoters are blocked by a stable complex in about half of 
the cells. 
 
Heavy transcription correlates with increased DNA accessibility of yeast gene bodies. We 
treated exponentially growing yeast cells with 3-aminotriazole (3AT), which induces the amino 
acid starvation response mediated by the Gcn4 transcription factor (Hinnebusch and Natarajan 
2002). We have shown previously that 3AT induces heavy transcription of ARG1, HIS4 and a 
few other genes, resulting in chromatin disruption and loss of nucleosome occupancy over the 
coding region and flanking regions (Cole et al. 2014). As expected, the AluI accessibility of the 
ARG1 and HIS4 gene bodies increases after 3AT treatment, whereas the accessibility of AluI 
sites in GAL1, which is not induced by 3AT, is unaffected (Supplemental Fig. S4). We also note 
that growing cells and α-factor arrested cells have similar DNA accessibilities at the global level, 
suggesting that replication does not have a strong effect on global accessibility (Supplemental 
Fig. S4; compare with Fig. 3A).  
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The mouse hepatocyte genome is more accessible than the yeast genome. We performed the 
same experiment using mouse liver nuclei (Supplemental Fig. S1). AluI digestion resulted in a 
plateau at a median accessibility of ~34% (Fig. 4A). Thus, the mouse hepatocyte genome is more 
accessible than the yeast genome (~22%; Fig. 2B). Although this observation seems counter-
intuitive, given that the yeast genome is very active and lacks heterochromatin, it is consistent 
with the longer average nucleosome spacing in hepatocytes (~195 bp) (van Holde 1989) relative 
to yeast (~165 bp) (Supplemental Fig. S1). More insight is obtained by examining the chromatin 
structure in the vicinity of the average mouse promoter after alignment of all ~25,000 genes on 
the TSS (Fig. 4B). AluI digestion in the promoter NDR just upstream of the TSS reaches a 
plateau at ~45% accessibility, which is higher than in the flanking regions (~32% accessible/ 
~68% protected). The protection of genic DNA is consistent with a protected inner nucleosome 
core of 133 bp (68% of 195 bp), which is essentially the same as that observed for yeast genes 
(132 bp). Weak nucleosome phasing is apparent downstream.  
 
Inactive mouse gene promoters are accessible in some cells. We sorted the genes according to 
the DNase I hypersensitivity of their promoters in mouse hepatocytes. This analysis revealed two 
classes of promoter: hypersensitive and insensitive (Fig. 4C; Supplemental Fig. S5A) (Chereji 
and Clark 2018). After sorting using the same gene order, nucleosome positioning (MNase-Exo-
seq) data (Cole et al. 2016) and hepatocyte gene expression data show that genes with 
hypersensitive promoters are mostly active, with an NDR and phased nucleosomes, whereas 
genes with DNase I-insensitive promoters are inactive, lack phasing and have no NDR (Fig. 4C; 
Supplemental Fig. S5). A finer analysis of these data, using deciles, is presented in Supplemental 
Fig. S6. 
Analysis of the AluI data indicates that active genes show better phasing and higher NDR 
accessibility (~58%) than all genes (Fig. 4D; cf. Fig. 4B). On the other hand, DNA accessibility 
on both sides of the NDR is unchanged (~32%; Fig. 4D). In contrast, DNase I-insensitive genes 
are uniformly accessible (~32%), including promoters, with no evidence for an NDR or 
nucleosome phasing, consistent with the nucleosome positioning data (Fig. 4C). Although 
inactive promoters have a lower mean accessibility (~32%) than active promoters (~58%), they 
are at least partly accessible in ~1 in 3 haploid genomes (i.e. on at least one allele in half of these 
diploid cells). The unexpected accessibility of AluI sites in inactive promoters probably reflects 
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the lack of nucleosome phasing, such that regularly spaced, but unphased nucleosomal arrays 
result in protection of promoter AluI sites in cells where they are nucleosomal and exposure in 
the other cells where they are in linker DNA (cf. Fig. 3B). 
 
Euchromatin and heterochromatin have very similar DNA accessibilities. We compared the 
accessibilities of euchromatin and heterochromatin using a 15-state epigenetic model for mouse 
hepatocyte chromatin derived from histone modification patterns and ChIP-seq 
data for Pol II and CTCF (Bogu et al. 2015) (Fig. 5). The median absolute AluI-accessible 
fraction is similar for all 15 chromatin states (the plateau values range from ~29% to ~36%), 
indicating that all states are accessible, including all heterochromatin states and Polycomb-
repressed regions (Fig. 5A). Active promoters (states 5 and 7) and strong enhancers (states 6 and 
8) were defined in the model of Bogu et al. (2015) primarily by the presence of the H3-K4me1, 
H3-K4me3, H3-K27ac histone marks and Pol II, whereas insulators were defined primarily by 
CTCF binding (state 15). All three of these regulatory elements are more accessible to AluI than 
the euchromatin and heterochromatin states, because they are short and dominated by an NDR, 
which has a higher average accessibility than the flanking chromatin (Fig. 4D, left panel). (Note 
that the accessibility of active promoters (~36%; Fig. 5A) averages lower than at promoter NDRs 
(58%; Fig. 4D), because the epigenetic state model includes both the NDR and its modified 
flanking nucleosomes.) Most importantly, the curves for the euchromatin states (1 and 2), 
defined by the H3-K36me3 mark (Bogu et al. 2015), track with those for the heterochromatin 
states, defined by the H3-K27me3 mark (Polycomb-repressed; state 11) or by the absence of 
active marks (states 12 - 14), indicating that the differences between them are negligible (Fig. 
5A). 
 The hidden Markov model used by Bogu et al. (2015) to define the various chromatin 
states did not include the histone marks typical of constitutive heterochromatin (H3-K9me2 and 
H3-K9me3). We confirmed that heterochromatin has a similar accessibility to euchromatin using 
two independent additional analyses. Firstly, we analyzed H3-K9me3 ChIP-seq data for adult 
mouse hepatocytes (Nicetto et al. 2019). These data indicate that constitutive heterochromatin 
defined by the H3-K9me3 mark has a somewhat lower but still quite similar average absolute 
accessibility (plateau at ~23%) than the heterochromatin states defined by Bogu et al. (2015) 
(~29%; Fig. 5A). In the case of Polycomb-repressed/ facultative heterochromatin, analysis of 
 Cold Spring Harbor Laboratory Press on May 14, 2020 - Published by genome.cshlp.orgDownloaded from 
10 
ChIP-seq data for H3-K27me3 from the same source (Nicetto et al. 2019) indicates a very similar 
average absolute accessibility (~28%) to that obtained for the same mark in the Bogu model 
(state 11; ~29%; Fig. 5A). Secondly, we used mouse genome annotations to determine the 
absolute AluI accessibilities of different annotated regions (Supplemental Fig. S7). We observed 
that all annotated regions have similar accessibilities except promoters (because of their NDRs, 
as discussed above). Most importantly, repeated sequences, which are strongly enriched in 
constitutive heterochromatin, have similar average absolute accessibility (~29%) to that of the 
heterochromatin states defined by Bogu et al. (~29%; Fig. 5A). 
Although the absolute AluI accessibilities (plateau values) are similar for euchromatin 
and heterochromatin, it seemed possible that they might be digested at very different rates, 
reflecting their very different degrees of compaction. Accordingly, we analyzed the initial AluI 
digestion rates for accessible sites in mouse chromatin (Fig. 5B, C). Regulatory elements 
containing NDRs (active promoters, insulators and strong enhancers) are digested about 3 times 
faster than the other chromatin states (cf. yeast NDRs; Supplemental Fig. S3). However, 
accessible sites in heterochromatin (states 11 - 14) are digested at virtually the same rate as those 
in euchromatin (active genes; states 1 and 2) (Fig. 5B, C). Similarly, the relative rate of AluI 
digestion of facultative heterochromatin as defined by Bogu et al. (2015) (state 11; ~1.2-fold) is 
very similar to that defined by H3-K27me3 ChIP-seq data (~1.3-fold) (Nicetto et al. 2019). The 
rate of digestion of constitutive heterochromatin defined by the H3K9me3 mark (~0.7-fold) is a 
little slower than for the various heterochromatin states of Bogu et al. (states 12, 13 and 14, 
which range from ~0.8 to ~1.1-fold), but this is a very small effect. If heterochromatin really 
blocks accessibility, a very large difference in AluI digestion rates for euchromatin and 
heterochromatin is expected, but it is not observed. Thus, DNA accessibility in mouse 
hepatocytes does not depend strongly on epigenetic state. 
 
Discussion 
Nucleosome spacing, phasing and DNA accessibility in chromatin. Our data indicate that 
access to most of the genome is blocked by nucleosomes in yeast (~78%) and in mouse 
hepatocytes (~68%), consistent with average nucleosome spacings of ~165 bp and ~195 bp, 
respectively, and a protected inner core of ~133 bp. Thus, nucleosome spacing is the major 
determinant of absolute DNA accessibility. The inner nucleosome core completely blocks AluI 
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but, since nucleosomes can occupy different positions in different cells (Shen et al. 2001; Cole et 
al. 2011; Small et al. 2014), all AluI sites are accessible in some cells. Thus, DNA accessibility 
varies from cell to cell. In yeast, most nucleosomes are phased, but nucleosome positioning is not 
strong enough to guarantee the inaccessibility of specific sites (Fig. 3). In mouse cells, most 
nucleosomes are regularly spaced, but are only well-positioned (phased) in the vicinity of active 
regulatory elements. Although inactive promoters have no NDR or phased nucleosomes, the 
nucleosomes are still regularly spaced, such that the probability of an AluI site being in the linker 
is determined by the average spacing. 
The plateau in AluI digestion indicates that protection is stable during the 20 minute 
digestion period, which is inconsistent with widespread nucleosome mobility in isolated nuclei, 
which would predict continued digestion if nucleosomes slide back and forth, alternately 
exposing and burying AluI sites. Nucleosomes may be more mobile in vivo due to the activities 
of various ATP-dependent chromatin remodelers capable of moving nucleosomes. It is likely  
that isolation of nuclei “freezes” the chromatin structure in the absence of ATP. Nucleosome 
mobility in vivo would be expected to increase the accessibility of DNA in chromatin. 
 
Accessibility of promoter NDRs. The typical promoter NDR in yeast and mouse is inaccessible 
to AluI in ~40% of cells. What is the source of this protection? Some protection can be attributed 
to residual nucleosome occupancy, as shown by MNase-seq data. On the other hand, many 
NDRs are almost nucleosome-free, but still protected in ~40% of cells (e.g. ARG1 site 8 in Fig. 
2A). Transcription factors are unlikely to provide much protection since they typically have fast 
on/off kinetics, resulting in windows of opportunity for AluI. Instead, based on our previous 
work (Nagarajavel et al. 2013; Chereji et al. 2017), we propose that NDR protection is largely 
due to stable complexes resembling the TFIIIB-TFIIIC complex found at tRNA genes, which has 
a stability similar to that of a nucleosome. Barrier complexes are thought to be responsible for 
nucleosome phasing, but their composition is unknown and may differ from one promoter to the 
next. Such barrier complexes must be stably bound during the 20 minute digestion to explain the 
observed plateau. Unlike the nucleosome, which bestows almost uniform protection to the DNA 
wrapped around its central core, barrier complexes may contain stretches of accessible DNA. In 
the case of the TFIIIB-TFIIIC complex, there is an MNase-sensitive site located between TFIIIB 
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and TFIIIC (Nagarajavel et al. 2013). Thus the location of an AluI site within a barrier complex 
could determine whether it is accessible or not. 
 
DNase I hypersensitivity, ATAC-seq and AluI digestion at promoters. The hypersensitivity 
of active promoters to DNase I and the contrast between active and inactive promoters (compare 
the top and bottom halves of the heat map in Fig. 4C) suggests a very large difference in 
promoter accessibility between active and inactive promoters. In contrast, our AluI data indicate 
that the difference in absolute accessibility is quite small: ~58% at the average active promoter 
NDR compared with ~32% at inactive promoters (which have no NDR) (Fig. 4D). Similarly, our 
data also reveal that the difference in initial AluI digestion rates between active promoters and 
chromatin lacking NDRs is only ~3-fold (Fig. 5B, C). To reconcile these apparently different 
results, we note that DNase I hypersensitivity correlates with the presence of a promoter NDR 
(MNase-seq data; Fig. 4C) and that DNase I data derive from short DNA fragments released at a 
very early stage in digestion and so are heavily enriched for open chromatin states (NDRs); the 
rest of the genome is not sequenced. DNA fragments from open promoters are therefore 
amplified relative to the rest of the genome, resulting in a large artificial difference in 
accessibility between active and inactive promoters. Similar considerations apply to all methods 
that sequence only the initial digestion products, including typical ATAC-seq experiments. In 
our qDA-seq method, all of the DNA fragments are sequenced. We also perform an enzyme 
titration to prove that the accessibility limit (plateau) has been reached, but this is not possible 
with DNase-seq, since DNase I is not completely blocked by nucleosomes. 
More generally, the DNase I hypersensitivity and Tn5 transposase (ATAC-seq) 
sensitivity of a promoter depend on two factors: (i) The fraction of accessible promoters: An 
AluI site in a specific active, open promoter is accessible in some cells but not in the others 
(information not provided by DNase I or ATAC-seq data). The higher this fraction is, the more 
DNase I or transposase cutting there would be. (ii) The width of the NDR (target size): The 
wider the NDR, the higher the probability of DNase I or transposase cleavage, because they are 
non-specific nucleases (sequence preference may be another important factor). This is clear from 
the heat maps in Fig. 4, in which the promoters with the most DNase I cleavage are also the ones 
with the widest NDRs (compare the tops of the DNase I and MNase-seq heat maps). A promoter 
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is unlikely to contain more than one AluI site and so the target size is a much less important 
factor. 
Alternative methods for quantitative measurement of DNA accessibility involve the use 
of DNA methyltransferases. These enzymes can be used to methylate cytosines in accessible 
CpG or GpC dinucleotides, which can then be identified by their resistance to bisulphite 
conversion after sequencing (e.g. NOMe-seq (Kelly et al. 2012) or MAPit (Nabilsi et al. 2014)). 
The methylation pattern reveals the footprints of nucleosomes and other stably bound proteins 
and therefore has a much higher resolution than qDA-seq (which is limited by the distribution of 
restriction sites), although it is not as good as MNase-seq. This approach requires considerably 
more sequence coverage than qDA-seq and the bioinformatic analysis is much more complex. 
 
Restriction enzymes as proxies for sequence-specific transcription factors. Since restriction 
enzymes are sequence-specific, they may be considered proxies for transcription factors. 
Sequence-specific transcription factors must search the DNA sequence to find their cognate 
binding sites. The search process is facilitated by one-dimensional diffusion of the transcription 
factor along the DNA in non-specific binding mode, with occasional dissociation and re-
association events (Halford and Marko 2004; Woringer and Darzacq 2018). Both transcription 
factors and restriction enzymes find their cognate sites using this type of mechanism. When a 
transcription factor locates a cognate site, it remains bound for a relatively long time and may 
recruit other factors. A restriction enzyme locates a cognate site in the same way, but then cuts 
the DNA instead, providing a record of that binding event, which we detect and quantify in our 
experiment. We note that the AluI concentration range used in our experiments is in the expected 
range for transcription factors (up to ~50 nM). 
 
Mouse promoter accessibility and gene repression. The accessibility of AluI sites in inactive 
hepatocyte promoters implies that transcription factors can bind their cognate sites in inactive 
promoters in some cells, depending on whether the site is in a linker or not, and that gene 
inactivity is not primarily due to binding site occlusion. Thus, our data are inconsistent with a 
simple repression model in which positioned nucleosomes prevent transcription factors from 
binding their cognate sites. Although cognate sites in inactive promoters are accessible in some 
cells because they are located in linker DNA, an NDR is not created, suggesting that 
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transcription factor access to DNA is insufficient for gene activation. Thus, events downstream 
of initial transcription factor binding determine whether a gene is active or not (Chen and Widom 
2005). We propose that the key is the formation of the stable complex represented by the NDR. 
Pioneer factors (defined as sequence-specific transcription factors capable of binding 
nucleosomal sites with high affinity (Zaret and Mango 2016)) may be critical, because they have 
the potential to bind their sites in all cells in a population, whether or not they are occupied by a 
nucleosome. If so, gene activation would depend on whether the pioneer factor is expressed. 
However, for reasons that are unclear, some pioneer factors cannot access all of their sites in 
vivo (Donaghey et al. 2018). An alternative model is that the key to NDR formation may be the 
clustering of transcription factor binding sites at promoters and enhancers; several specific 
transcription factors may have to be expressed and bind in concert to form an NDR before a gene 
can be activated. In this cooperative multi-site model (Adams and Workman 1995; Mirny 2010), 
single factor binding events at cognate sites in linker DNA would not be sufficient for NDR 
formation; all of the factors involved would need to be expressed to initiate NDR formation and 
gene activation. 
 
Heterochromatin and euchromatin have similar DNA accessibilities. Our data indicate that 
heterochromatin is not generally less accessible than euchromatin. This conclusion is consistent 
with a recent quantitative analysis of MNase-seq data for human cells (Schwartz et al. 2018). We 
note that some accessibility is expected given that constitutive heterochromatin must be 
transcribed to produce the RNA required for its repression (Grewal 2010). Our data indicate that 
transcription factors would be expected to penetrate heterochromatin, even in its extremely 
compact state. However, the size of the transcription factor may be critical. Although AluI, 
which is a monomer with a relative molecular mass of ~46,000, is similar in size to many 
transcription factors, theoretical modeling suggests that much larger complexes may be excluded 
from compact heterochromatin (Maeshima et al. 2015). This is a distinct possibility given that 
many transcription factors are associated with large complexes. 
 
Methods 
AluI digestion of yeast nuclei. Yeast strain YDC111 (MATa ade2-1 can1-100 leu2-3,112 trp1-
1 ura3-1 (Kim et al. 2006)) was grown at 30◦C in synthetic complete (SC) medium to A600 = 
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∼0.2 and arrested in G1 by addition of α-factor (FDA Core Facility) to 10 μg/ml. Arrest was 
monitored by observing the appearance of the “shmoo” phenotype in a light microscope. After 2 
h, the cells were harvested by filtration and stored at -80◦C. Spheroplasts were prepared from 
∼100 A600 units of cells in 15 ml SM Buffer (SC medium with 1 M sorbitol, 50 mM Tris-HCl pH 
8.0, 20 mM 2-mercaptoethanol) by digestion with ∼26,000 units of lyticase (Sigma-Aldrich L-
2524) at 30◦C for 5 min or less. Digestion of the cell wall was monitored by measuring the A600 
of 30 μl cell suspension in 1 ml 1% SDS and considered complete when the A600 decreased to < 
10% of the initial value. For 3AT experiments, YDC111 cells were grown to mid-log phase at 
30◦C either in SC medium lacking histidine, followed by addition of 3AT (Sigma-Aldrich 61-82-
5) to 10 mM for 20 min, or in SC medium (control), and stored as above. Spheroplasting of 3AT-
treated cells was carried out in SM medium lacking histidine. Spheroplasts were centrifuged in a 
pre-cooled Sorvall SA600 rotor (7,500 rpm for 5 min at 4◦C) and washed once with 25 ml cold 
ST Buffer (1 M sorbitol, 50 mM Tris-HCl pH 8.0). Spheroplasts were lysed by resuspension in 
20 ml cold F Buffer (18% w/v Ficoll-PM400 (GE Healthcare 17-0300-50), 40 mM potassium 
phosphate, 1 mM magnesium chloride, pH 6.5; protease inhibitors (Roche 05056489001) and 5 
mM 2-mercaptoethanol were added just before use). The lysate was applied to a step gradient of 
15 ml cold FG Buffer (7% w/v Ficoll-PM400, 20% glycerol, 40 mM potassium phosphate, 1 mM 
magnesium chloride, pH 6.5, with protease inhibitors and 5 mM 2-mercaptoethanol as above) 
and centrifuged in an SA600 rotor (12,500 rpm for 20 min at 4◦C). The pellets (crude nuclei) 
were resuspended in 4.4 ml pre-warmed AluI Digestion Buffer (10 mM HEPES pH 7.5, 35 mM 
NaCl, 5 mM MgCl2, with protease inhibitors and 5 mM 2-mercaptoethanol) and divided into 
eleven 400 μl aliquots. AluI (New England Biolabs R0137 at 0.015 mg/ml; MW = 46,000) was 
added (0, 1, 2.5, 5, 10, 20, 40, 100, 200, 400, 800 units), mixed thoroughly, and incubated at 
25◦C for 20 min. Digestion was stopped by adding 50 μl 90 mM EDTA, 9% SDS. Aliquots (180 
μl) were removed from each digest to ascertain the level of digestion; the remainders were stored 
at -20◦C prior to sonication. For gel analysis, the DNA was purified by addition of 10 μl 20% 
SDS, mixing, addition of 50 μl 5 M potassium acetate, followed by two extractions with an equal 
volume of chloroform, precipitation with 0.7 vol. isopropanol, and one wash with 75% ethanol. 
The purified DNA was dissolved in 20 μl 10 mM Tris-HCl pH 8.0, 0.1 mM EDTA, 0.5 mg/ml 
RNase A and incubated at 37◦C for 1 h. The DNA was analyzed in a 1% agarose gel stained with 
SYBR-Gold (Invitrogen S11494). For sonication, the samples were adjusted to 450 μl with 180 
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μl AluI Digestion Buffer, transferred to 15-ml Sumilon TPX tubes (Diagenode C30010009) and 
sonicated using a Diagenode Bioruptor 300 at 4◦C and high power: 20 cycles of 30 s on and 30 s 
off. The DNA was purified, treated with RNase as above, purified again using Qiagen PCR 
purification columns (Qiagen 28106) and eluted in 50 μl 10 mM Tris-HCl pH 8.0, 0.1 mM 
EDTA (TE(0.1)). Concentrations were determined by measuring A260. The degree of sonication 
was checked by analysis in a 2% agarose gel stained with SYBR-Gold; DNA sizes ranged from 
∼100 to ∼700 bp. Prior to library preparation, the DNA was treated with repair enzymes (New 
England Biolabs PreCR kit M0309) and purified using Qiagen PCR purification columns as 
above. 
AluI digestion of mouse liver nuclei. Livers were dissected from pregnant (E13.5) female 
NIH/Swiss mice and stored at -80◦C. For each experiment, a liver was thawed on ice and gently 
disrupted in a glass homogenizer containing 12 ml cold Buffer A per gram liver (Buffer A: 0.34 
M sucrose, 60 mM KCl, 15 mM NaCl, 15 mM Tris-HCl pH 8.0, 0.5 mM spermidine-HCl, 0.15 
mM spermine, 1 mM Na-EDTA, 15 mM 2-mercaptoethanol, and protease inhibitors as above). 
The homogenate was filtered through four layers of cheesecloth into a 50-ml tube on ice. Crude 
nuclei were collected by applying the filtrate to two 4-ml step gradients of Buffer A with 1 M 
sucrose in 15-ml tubes and spinning in a Sorvall SA600 rotor at 12,500 rpm for 15 min at 4◦C. 
The supernatants were decanted and solid material on the tube sides was removed with a tissue. 
The nuclei were washed by gentle resuspension of both pellets in a total of 5 ml Buffer A and 
centrifuged for 5 min as above. The supernatant was removed, the pellet resuspended in 1 ml 
Buffer A, and placed on ice. The DNA concentration was estimated by measuring the A260 of 2 
μl nuclei in 1 ml 1 M NaOH. The volume of nuclei corresponding to 50 A260 units was 
transferred to a 1.5-ml microfuge tube and centrifuged for 5 min at 14,000 rpm at 4◦C. The 
supernatant was removed and the nuclei were resuspended in 1 ml Mouse AluI Digestion Buffer 
(0.34 M sucrose, 60 mM KCl, 15 mM NaCl, 15 mM Tris-HCl pH 8.0, 5 mM MgCl2, 15 mM 2-
mercaptoethanol, with protease inhibitors as above). The A260 of the diluted nuclei (10 μl) was 
measured as above. Twelve aliquots of carefully resuspended nuclei, each containing 20 μg DNA 
in 200 μl Digestion Buffer, were titrated with AluI as follows: 0, 0.3, 0.6, 1.3, 2.5, 5, 10, 20, 40, 
80, 160, 320 units. The samples were mixed gently but thoroughly with a 1-ml pipette and 
incubated at 37◦C for 20 min. Digestion was stopped by adding 200 μl 2% SDS, 20 mM EDTA, 
10 mM Tris-HCl pH 8.0, mixing thoroughly and incubating for 40 min at room temperature to 
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ensure complete protein removal from DNA. The extent of digestion was determined by analysis 
of DNA purified from 50 μl of each digest in an agarose gel, after RNase treatment as above. 
The remaining 350 μl was stored at -20◦C prior to sonication. The samples were warmed to room 
temperature to dissolve precipitated SDS, the volumes were adjusted to 450 μl with 100 μl 10 
mM TE(0.1) and sonicated as above. The DNA was purified as above and dissolved in 45 μl 50 
mM Tris-HCl pH 8.0, 5 mM EDTA, 0.1 mg/ml RNase A and incubated for 1 h at 37◦C. The salt 
concentration was adjusted by addition of 5 μl 10x NEB Buffer 4 and the DNA was purified 
using Qiagen PCR columns. DNA was eluted in 50 μl TE(0.1). Concentrations were measured 
by A260. The degree of sonication was checked by analysis in a 2% agarose gel; DNA sizes 
ranged from ∼100 to ∼700 bp. 
Illumina paired-end library preparation. The Illumina paired-end adaptor was ligated to ∼500 
ng purified sonicated AluI-digested DNA using the NEBNext Ultra DNA library kit for Illumina 
(New England Biolabs E7370) according to the manufacturer’s instructions. The ligated DNA 
samples were purified without size selection using AMPure XP beads at a 1:1 ratio (Beckman 
A63880). The DNA (50-100 ng) was amplified using the Phusion Hi-Fi PCR master mix with 
HF buffer (New England Biolabs M0531) or the Q5 Hot Start HiFi PCR master mix (New 
England Biolabs E6625AA) (7 - 10 cycles). Library quality was checked in an agarose gel. 
Sequencing was performed using either an Illumina HiSeq 2500 or an Illumina NextSeq 500. 
Bioinformatics and data analysis. Paired-end reads were aligned to the S. cerevisiae reference 
genome sacCer3, or to the M. musculus reference genome mm10, using Bowtie 2 (Langmead 
and Salzberg 2012) with the parameters -X 5000 --very-sensitive, to map sequences up to 5 kb 
with maximum accuracy. Coverage information is given in Supplemental Fig. S8. For every AluI 
motif (AGCT) found in the genome, we estimated the fraction of nuclei in which the given motif 
was cleaved by AluI, fcut = Ncut/(Ncut + Nuncut), by counting the number of reads that were cut at 
this site (with an end at this site), Ncut, and the number of reads that were not cut at this site 
(overlapping the motif), Nuncut, using the Bioinformatics toolbox from MATLAB. The fact that a 
cut site will generate two fragment ends was accounted for as follows: AluI cleavage produces a 
left fragment ending with AG and a right fragment starting with CT. For every site, the number 
of fragments ending at AG,  
 





, and the 
number of fragments containing intact sites,  
 
, was counted. Two estimations of the cut 





























, are obtained, which theoretically should 
be equal. Because we sequenced 50 nucleotides from both ends of the DNA fragments, we 
discarded the AluI sites which were separated by less than 50 bp apart, as the reads originating 
from cleavages at both sites were underrepresented in the properly aligned reads. Duplicate reads 
were not removed for two reasons: (1) they occur at low frequency in the sonicated “0 nM AluI” 
controls (~2% of reads in the yeast data after exclusion of the rDNA, for which the probability of 
genuine duplicate reads is much higher than for unique sequences); (2) the probability of a 
genuine duplicate read corresponding to fragments cut with AluI at both ends is much higher 
than random (~9% of reads in the most digested AluI samples (54 nM) are duplicates; rDNA 
excluded) and it is therefore important not to remove duplicates to avoid skewing the data. We 
also note that the probability of a genuine duplicate increases with the number of reads. GEO 
database data used: MNase-Exo-seq (GSE65889), DNase-seq (GSM1014183 in GSE37074) and 
RNA-seq (GSM2071423 and GSM2071424 in GSE78391). 
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Figure 1. A fully quantitative assay for DNA accessibility in chromatin. (A) DNA accessibility 
may depend on the degree of chromatin compaction. (B) Principle of the restriction enzyme 
protection assay. 
 
Figure 2. DNA accessibility in yeast varies from cell to cell. (A) AluI accessibility of the ARG1 
gene in arrested haploid yeast cells. Upper panel: Nucleosome occupancy (MNase-seq data 
(Ocampo et al. 2016)) in wild type cells normalized to the genomic average (= 1). Ovals indicate 
approximate nucleosome positions. Lower panel: AluI digestion at each of nine sites (data for 
two independent experiments are shown). The plateau value is a measure of the fraction of cells 
in which the AluI site is accessible. Each site is accessible in some cells and inaccessible in the 
rest. (B) Digestion kinetics for all ~40,000 AluI sites as a function of [AluI] (11 digestion points) 
for haploid cells arrested with α-factor. Red line: median level of digestion. Pink shading 
indicates data ranges: the lightest pink area includes 90% of the AluI sites (i.e. the 5%-95% data 
range, which excludes the 5% of AluI sites that are the least cut and the 5% of sites that are the 
most cut). Lower panel: Initial stages of digestion. (C) Kinetics for AluI sites in gene bodies 
(between start and stop codons) and promoter NDRs defined using the positions of the +1 and -1 
nucleosomes (Chereji et al. 2018). Blue line: median level of digestion in NDRs; green line: 
median level of digestion in gene bodies.  
 
Figure 3. Genomic analysis of AluI accessibility reveals imperfect nucleosome phasing in yeast.   
(A) Mean accessibility as a function of distance from the center of the +1 nucleosome (defined 
by (Chereji et al. 2018) on all ~5,000 yeast genes. (B) Heterogeneous nucleosome positioning 
model to explain the AluI accessibility data. On a typical gene, nucleosomes are positioned 
slightly differently in each cell such that a particular AluI site is inside a nucleosome in one cell 
and in a linker in another cell. The cartoon shows the nucleosome positions on a gene in five 
different cells. An AluI site in the coding region is in the linker (accessible) in only one cell out 
of five (20% accessibility), whereas an AluI site in the promoter NDR is accessible in three out 
of five cells (60% accessibility). The observed average values are ~25% in the coding region and 
~55% in the NDR (see A). 
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Figure 4. Inactive gene promoters are accessible to AluI in some mouse liver cells. (A) AluI 
digestion of mouse hepatocyte nuclei (12 digestion points) Left panel: all data. Right panel: 
initial digestion. The data range shows that 80% of AluI sites (with at least 5 reads) are cut in 5% 
- 60% of cells. (B) Average AluI accessibility plotted as a function of distance from the TSS on 
all ~25,000 mouse genes. Grey area: MNase-Exo-seq data (nucleosome dyads (Cole et al. 2016)) 
on an arbitrary scale. (C) Heat map analysis of all ~25,000 mouse genes sorted according to the 
DNase I hypersensitivity of their promoters in mouse hepatocytes (data from ENCODE) and 
aligned on the TSS: left panel: DNase I cut density; middle: nucleosome dyad positions (Cole et 
al. 2016); right: RNA-seq data (two biological replicates from ENCODE). The white line divides 
hypersensitive and insensitive promoters (defined in Supplemental Fig. S5). (D) Average AluI 
accessibility plotted as a function of distance from the TSS for DNase I hypersensitive and 
DNase I insensitive promoters defined in C. (E) Distribution of AluI cut fractions corresponding 
to all AluI sites located in promoters (region [TSS - 185 bp; TSS + 85 bp]), separated by DNase I 
hypersensitivity. 
 
Figure 5. Heterochromatin and euchromatin have very similar DNA accessibilities in mouse 
hepatocytes. (A) AluI digestion kinetics for sites in the 15 epigenetic chromatin states in mouse 
hepatocytes defined by (Bogu et al. 2015), for sites in repeated sequences (defined by 
RepeatMasker), and for sites marked by H3K9me3 (constitutive heterochromatin) or H3K27me3 
(facultative heterochromatin) (data from Nocetti et al., 2019). (B) Initial rates of AluI digestion. 
(C) Quantitative comparison of initial digestion rates for the 15 epigenetic states defined by 
Bogu et al. (2015), repeated sequences and regions marked by H3K9me3 or H3K27me3. Data 
for biological replicate experiments A and B are shown. See Supplemental Material for details of 
the analysis. 
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